Study to Evaluate the Effect of a Very Low Carbohydrate Diet on Gastroesophageal Reflux Disease
This study has been completed.
Sponsor:
University of North Carolina, Chapel Hill
Collaborator:
Takeda Pharmaceuticals North America, Inc.
Information provided by (Responsible Party):
Nicholas Shaheen, University of North Carolina, Chapel Hill
ClinicalTrials.gov Identifier:
NCT00998244
First received: October 2, 2009
Last updated: January 6, 2012
Last verified: January 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this research study is to learn if a very low carbohydrate (sugar) diet or traditional low fat diet is able to reduce symptoms related to gastroesophageal reflux disease (GERD) in people who are overweight. Patients with GERD may experience all or some of the following symptoms: stomach acid or partially digested food re-entering the esophagus (which is sometimes referred to as heartburn or regurgitation) and belching. In this study, the investigators also hope to find out if acid in the esophagus is reduced more by a low carbohydrate diet than a low fat diet.
| Condition | Intervention |
|---|---|
|
Gastroesophageal Reflux Disease Overweight Acid Reflux Disease |
Other: Diet - very low carb or low fat |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Crossover Assignment Masking: Double Blind (Subject, Investigator, Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | A Randomized, Double-Blind Crossover Study to Evaluate the Effect of a Very Low Carbohydrate Diet on Gastroesophageal Reflux Disease |
Resource links provided by NLM:
Further study details as provided by University of North Carolina, Chapel Hill:
Primary Outcome Measures:
- Change in distal esophageal acid exposure after initiating a very low carbohydrate diet compared to the decrease seen after initiating a low fat diet [ Time Frame: Baseline, 10 days after baseline, and at 25 days after baseline. ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- The change in serum levels of pro-inflammatory cytokines after initiating a very low carbohydrate diet compared to a traditional low fat diet as measured with blood samples. [ Time Frame: Baseline, 10 days after baseline, and at 25 days after baseline ] [ Designated as safety issue: No ]
| Enrollment: | 40 |
| Study Start Date: | September 2009 |
| Study Completion Date: | December 2011 |
| Primary Completion Date: | December 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Very Low Carbohydrate Diet
Very Low Carbohydrate Diet
|
Other: Diet - very low carb or low fat
Diet comparison in Gastroesophageal Reflux Disease
|
|
Active Comparator: Low Fat Diet
Low Fat Diet
|
Other: Diet - very low carb or low fat
Diet comparison in Gastroesophageal Reflux Disease
|
Eligibility| Ages Eligible for Study: | 18 Years to 70 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- 18 to 70 years old
- BMI between 30 kg/m2 and 45 kg/m2
Exclusion Criteria:
- Known history of Barrett's esophagus or esophageal adenocarcinoma
- Previous surgical anti-reflux procedure
- Previous weight loss surgery, including gastric bypass
- Diabetes
- Pregnancy
- Heart Disease
- Unwillingness to discontinue use of proton pump inhibitors (PPI's) or H2-receptor antagonists per study protocol
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00998244
Locations
| United States, North Carolina | |
| The University of North Carolina at Chapel Hill | |
| Chapel Hill, North Carolina, United States, 27514 | |
Sponsors and Collaborators
University of North Carolina, Chapel Hill
Takeda Pharmaceuticals North America, Inc.
Investigators
| Principal Investigator: | Nicholas J Shaheen, MD, MPH | University of North Carolina, Chapel Hill |
More Information
No publications provided
| Responsible Party: | Nicholas Shaheen, Professor of Medicine, University of North Carolina, Chapel Hill |
| ClinicalTrials.gov Identifier: | NCT00998244 History of Changes |
| Other Study ID Numbers: | 07-0623 |
| Study First Received: | October 2, 2009 |
| Last Updated: | January 6, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by University of North Carolina, Chapel Hill:
|
low carbohydrate low fat diet overweight |
GERD gastroesophageal reflux disease acid reflux heartburn |
Additional relevant MeSH terms:
|
Gastroesophageal Reflux Overweight Esophageal Motility Disorders Deglutition Disorders Esophageal Diseases |
Gastrointestinal Diseases Digestive System Diseases Body Weight Signs and Symptoms |
ClinicalTrials.gov processed this record on May 19, 2013